Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) rapidly infects
humans and animals which make coronavirus disease 2019 (COVID-19) a grievous …

The recent pandemic which arose from China, is caused by a pathogenic virus named
“severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2)”. Its rapid global …

Tweetable abstract Toll-like receptor 4, an innate immune sensor, is one of the key 'fate-
deciding'regulators of immunity as well as COVID-19 immunopathogenesis. Suitable …

The aim of this study was to investigate the clinical efficacy of a combination of nirmatrelvir
and ritonavir (NMV‐r) for treating COVID‐19 in patients with diabetes mellitus (DM). This …

Mutation (s) in the spike protein is the major characteristic trait of newly emerged SARS-CoV-
2 variants such as Alpha (B. 1.1. 7), Beta (B. 1.351), Gamma (P. 1), Delta (B. 1.617. 2), and …

Abstract Background Toll-like receptors (TLRs) play a pivotal role in the immunologic
response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection …

The recent identification of the involvement of the immune system response in the severity
and mortality of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection highlights …

Diverse clinical and laboratory features of multisystem inflammatory syndrome (MIS‐C) have
been reported in the literature. Despite the worldwide distribution, systemic studies …

Clinical evidence indicates that COVID‐19 is a multiorgan disease that significantly impacts
the cardiovascular system. However, little is known about the predictors of myocardial …

Betacoronaviruses (β-CoVs) have caused major viral outbreaks in the last two decades in
the world. The mutation and recombination abilities in β-CoVs resulted in zoonotic diseases …